Matthew Harrison
Stock Analyst at Morgan Stanley
(3.39)
# 880
Out of 4,842 analysts
727
Total ratings
47.1%
Success rate
2.52%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Maintains: Overweight | $182 → $113 | $37.23 | +203.52% | 36 | May 7, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $462 → $464 | $445.10 | +4.25% | 38 | May 6, 2025 | |
| GILD Gilead Sciences | Maintains: Overweight | $130 → $135 | $108.44 | +24.49% | 41 | Apr 25, 2025 | |
| AVIR Atea Pharmaceuticals | Maintains: Equal-Weight | $6.2 → $6 | $2.94 | +104.43% | 10 | Apr 11, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $157 → $152 | $127.53 | +19.19% | 52 | Apr 9, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $39 → $32 | $26.05 | +22.84% | 25 | Apr 9, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $82 → $80 | $28.29 | +182.79% | 11 | Mar 17, 2025 | |
| TNYA Tenaya Therapeutics | Maintains: Overweight | $15 → $5 | $0.44 | +1,031.99% | 5 | Mar 12, 2025 | |
| DNLI Denali Therapeutics | Assumes: Overweight | $41 → $33 | $13.04 | +153.07% | 12 | Mar 7, 2025 | |
| LYV Live Nation Entertainment | Maintains: Buy | $160 → $178 | $140.22 | +26.94% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $36.34 | +54.10% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $90 | $66.36 | +35.62% | 16 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $34.63 | +58.82% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $1.42 | +111.27% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1,235 → $1,184 | $591.85 | +100.05% | 50 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $4 → $6 | $1.19 | +404.20% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $12.95 | -15.06% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $1.25 | +540.00% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $510 | $576.24 | -11.50% | 24 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $1.87 | +274.33% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $112 | $58.09 | +92.80% | 21 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $15.46 | +119.92% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $21.19 | +51.01% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $1.27 | +1,396.06% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underweight | $60 | $4.98 | +1,104.82% | 30 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $13 | $7.89 | +64.77% | 4 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $0.85 | +18.25% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $19.12 | -47.70% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $6.90 | +15.94% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $29.08 | +51.31% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $2.25 | +477.78% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $4 | $0.41 | +875.61% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5 → $3 | $0.30 | +895.36% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $97.53 | +121.47% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $2.65 | +88.68% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.85 | +170.27% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $183.09 | -0.60% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $3.50 | +157.14% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $45.32 | -11.74% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $278.40 | +1.29% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $285.81 | -26.52% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $23.18 | +124.33% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $152.43 | +13.49% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $61 → $57 | $6.48 | +780.31% | 9 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $34.35 | +249.34% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $15.06 | +882.74% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $76.17 | +7.65% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $46.97 | +40.52% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $2.44 | +1,498.36% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $32.63 | +40.97% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $9.15 | +282.51% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $719.39 | -61.77% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.01 | +845.27% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $8.54 | +626.00% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $15.56 | +10.86% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $50 | $0.68 | +7,242.14% | 4 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $64.93 | +27.83% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $59 → $57 | $29.54 | +92.96% | 4 | Oct 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $30.28 | -66.97% | 4 | Sep 10, 2018 |
Sarepta Therapeutics
May 7, 2025
Maintains: Overweight
Price Target: $182 → $113
Current: $37.23
Upside: +203.52%
Vertex Pharmaceuticals
May 6, 2025
Maintains: Equal-Weight
Price Target: $462 → $464
Current: $445.10
Upside: +4.25%
Gilead Sciences
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $108.44
Upside: +24.49%
Atea Pharmaceuticals
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $2.94
Upside: +104.43%
Biogen
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $157 → $152
Current: $127.53
Upside: +19.19%
Moderna
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $39 → $32
Current: $26.05
Upside: +22.84%
Legend Biotech
Mar 17, 2025
Maintains: Overweight
Price Target: $82 → $80
Current: $28.29
Upside: +182.79%
Tenaya Therapeutics
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.44
Upside: +1,031.99%
Denali Therapeutics
Mar 7, 2025
Assumes: Overweight
Price Target: $41 → $33
Current: $13.04
Upside: +153.07%
Live Nation Entertainment
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $140.22
Upside: +26.94%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $36.34
Upside: +54.10%
Feb 6, 2025
Maintains: Overweight
Price Target: $85 → $90
Current: $66.36
Upside: +35.62%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $34.63
Upside: +58.82%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.42
Upside: +111.27%
Nov 1, 2024
Maintains: Overweight
Price Target: $1,235 → $1,184
Current: $591.85
Upside: +100.05%
Sep 16, 2024
Maintains: Overweight
Price Target: $4 → $6
Current: $1.19
Upside: +404.20%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $12.95
Upside: -15.06%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $1.25
Upside: +540.00%
May 28, 2024
Maintains: Overweight
Price Target: $515 → $510
Current: $576.24
Upside: -11.50%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $1.87
Upside: +274.33%
Apr 26, 2024
Maintains: Overweight
Price Target: $115 → $112
Current: $58.09
Upside: +92.80%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $15.46
Upside: +119.92%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $21.19
Upside: +51.01%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $1.27
Upside: +1,396.06%
Jul 11, 2023
Reiterates: Underweight
Price Target: $60
Current: $4.98
Upside: +1,104.82%
Mar 27, 2023
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $7.89
Upside: +64.77%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $0.85
Upside: +18.25%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $19.12
Upside: -47.70%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $6.90
Upside: +15.94%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $29.08
Upside: +51.31%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $2.25
Upside: +477.78%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $4
Current: $0.41
Upside: +875.61%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $5 → $3
Current: $0.30
Upside: +895.36%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $97.53
Upside: +121.47%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.65
Upside: +88.68%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.85
Upside: +170.27%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $183.09
Upside: -0.60%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $3.50
Upside: +157.14%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $45.32
Upside: -11.74%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $278.40
Upside: +1.29%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $285.81
Upside: -26.52%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $23.18
Upside: +124.33%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $152.43
Upside: +13.49%
Mar 10, 2022
Maintains: Equal-Weight
Price Target: $61 → $57
Current: $6.48
Upside: +780.31%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $34.35
Upside: +249.34%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $15.06
Upside: +882.74%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $76.17
Upside: +7.65%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $46.97
Upside: +40.52%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $2.44
Upside: +1,498.36%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $32.63
Upside: +40.97%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $9.15
Upside: +282.51%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $719.39
Upside: -61.77%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.01
Upside: +845.27%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $8.54
Upside: +626.00%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $15.56
Upside: +10.86%
Aug 18, 2020
Downgrades: Equal-Weight
Price Target: $50
Current: $0.68
Upside: +7,242.14%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $64.93
Upside: +27.83%
Oct 11, 2018
Maintains: Overweight
Price Target: $59 → $57
Current: $29.54
Upside: +92.96%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $30.28
Upside: -66.97%